Accessibility Menu
 
China Pharma logo

China Pharma

(NYSEMKT) CPHI

Current Price$0.60
Market Cap$22.38M
Since IPO (2002)-100%
5 Year-100%
1 Year-71%
1 Month-12%

China Pharma Financials at a Glance

Market Cap

$22.38M

Revenue (TTM)

$4.14M

Net Income (TTM)

$3.19M

EPS (TTM)

$-0.75

P/E Ratio

-0.74

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$0.60

Volume

0

Open

$0.60

Previous Close

$0.60

Daily Range

$0.60 - $0.60

52-Week Range

$0.50 - $2.60

CPHI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About China Pharma

Industry

Pharmaceuticals

Employees

221

CEO

Zhi Lin Li

Headquarters

Haikou, 570216, CN

CPHI Financials

Key Financial Metrics (TTM)

Gross Margin

-3%

Operating Margin

-78%

Net Income Margin

-77%

Return on Equity

-21%

Return on Capital

-0%

Return on Assets

-0%

Earnings Yield

-1.35%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$22.38M

Shares Outstanding

40.52M

Volume

0

Avg. Volume

25.45K

Financials (TTM)

Gross Profit

$131.95K

Operating Income

$3.09M

EBITDA

$1.51M

Operating Cash Flow

$148.26K

Capital Expenditure

$137.25K

Free Cash Flow

$11.01K

Cash & ST Invst.

$345.11B

Total Debt

$183.18B

China Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.23M

+8.1%

Gross Profit

$150.78K

+370.9%

Gross Margin

12.30%

N/A

Market Cap

$22.38M

N/A

Market Cap/Employee

$99.89K

N/A

Employees

224

N/A

Net Income

$1.22M

+0.2%

EBITDA

$702.77K

+5.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$161.94B

+5463373.0%

Accounts Receivable

$290.67K

+3.4%

Inventory

$1.62T

+71549450.5%

Long Term Debt

$111.55B

+8018425.3%

Short Term Debt

$71.63B

+3255965.3%

Return on Assets

-0.00%

N/A

Return on Invested Capital

-0.00%

N/A

Free Cash Flow

$146.22K

+525.3%

Operating Cash Flow

$151.99K

-36.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
XBIOXenetic Biosciences, Inc.
$3.17+2.59%
FLGCFlora Growth Corp.
$7.79-32.14%
ENSCEnsysce Biosciences, Inc.
$0.39-2.50%
SNGXSoligenix, Inc.
$0.33+4.06%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.19-0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.14-0.12%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.58+0.05%
AMDAdvanced Micro Devices
$421.39+0.19%

Questions About CPHI

What is the current price of China Pharma?

China Pharma is trading at $0.60 per share.

What is the 52-week range for China Pharma?

Over the past 52 weeks, China Pharma has traded between $0.50 and $2.60.

How much debt does China Pharma have?

As of the most recent reporting period, China Pharma reported total debt of $3.60M.

How much cash does China Pharma have on hand?

China Pharma reported $345,112 in cash and cash equivalents in its most recent financial results.

What is China Pharma’s dividend yield?

China Pharma does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.